What is RNTX's market capitalization?

RNTX (RNTX) reported market capitalization of $36.45M in Q1 2026.

What does market capitalization mean?

The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.

RNTX RNTX Market capitalization

Market capitalization at other companies

Bristol-Myers SquibbBMY

$123.83B-0.2%

Gilead SciencesGILD

$172.99B+23.8%

AbbVieABBV

$384.69B+3.8%

CTO

Citius Oncology, Inc.CTOR

$54.72M-17.8%

Ethos Technologies, Inc. LIFE

$702.25M—

Gyre Therapeutics, Inc.GYRE

$636.46M-11.9%

Other financials

Income statement

See full

Revenue-—

Operating income-$5.2M+6.8%

Net income-$5.8M-6.1%

EPS (diluted)-$0.19+24.0%

Balance sheet

See full

Cash & equivalents$4.4M-40.2%

Total debt$48.0K0.0%

Total equity$6.9M-63.0%

Total assets$26.3M-54.4%

Cash flow

See full

Operating cash flow-$3.4M+44.6%

CapEx-—

Free cash flow-$6.3M—

Returns & leverage

See full

Return on equity-123.3%+86.1pp

Debt / equity0×0.0×

Current ratio0.4×-1.0×

Where this comes from

Computed from the period-end share price: $36.45M.

The official record: RNTX’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about RNTX's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is RNTX's market capitalization?: RNTX (RNTX) reported market capitalization of $36.45M in Q1 2026.
What does market capitalization mean?: The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.